30,000 procedures and counting. Canaloplasty is now available from Ellex.
We are pleased to advise that Ellex Medical has acquired the canaloplasty business of iScience Interventional.
Since introducing its range of canaloplasty products, iScience Interventional has been pushing the boundaries of glaucoma surgery to deliver an unprecedented level of efficacy and safety. This focus meshes perfectly with Ellex's ongoing commitment to provide advanced, innovative and effective solutions in the treatment of glaucoma. Today, more than 20,000 Ellex ophthalmic laser and ultrasound systems are in use around the world, including its proprietary selective laser trabeculoplasty (SLT) technology for the treatment of early-stage glaucoma.
The opportunity to combine canaloplasty and SLT under one roof is a great outcome for physicians and patients alike. It will also allow us to provide an ever-increasing level of glaucoma clinical support to each and every iScience and Ellex customer.
Dr. Robert Sinskey discusses his decision to have Canaloplasty on his own eye
Dr. Rick Lewis, one of the first US surgeons to adopt Canaloplasty, discusses his early experience with iScience and Canaloplasty, the challenges of bringing a new technology to market and the satisfaction that comes with overcoming those challenges. Dr. Lewis also discusses how Canaloplasty has enabled him to offer a safe and effective glaucoma treatment to his patients.
Dr. Regine Pappas, glaucoma specialist in Melbourne, FL discusses treating her mother for glaucoma. her decision to perform Canaloplasty and the positive outcome her mom had with the procedure
3 Year Data
At 3 years, Canaloplasty patients experienced a decrease in IOP of 34% and a reduction in medications of 53%.